Flexible Electronics News

Adamant Innotech, CSEM Developing Serological Test that Traces Previous Infections

Tests track the presence of specific antibodies in the blood that the body produces in response to an infection.

Author Image

By: Anthony Locicero

Copy editor, New York Post

Swiss startup Adamant Innotech and CSEM are developing a rapid, highly sensitive serological test to determine if a person has been previously infected with the SARS-CoV-2 virus (the causative agent of COVID-19) and other types of viruses.    The device will be based on mature optical microarray technology already used in other medical applications. The new biosensor is intended to give results in one to two hours after simultaneously probing for up to 20 different types of antibodies while ...

Continue reading this story and get 24/7 access to Ink World magazine for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Ink World magazine Newsletters